This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $445,648.00 to Mayo Clinic for its "Translational Training in Respiratory Disease and Repair" program. The objective is to train the next generation of basic, translational, and clinician scientists capable of advancing respiratory medicine to fully restore respiratory function. The 5-year grant (1/1/2025 - 12/31/2029) will fund 5 postdoctoral trainees mentored by 26 interdisciplinary faculty members across basic science and clinical departments. The program spans basic, translational, and clinical research on respiratory biology, physiology, and medicine, with a focus on developing novel therapies and tools to address acute and chronic respiratory conditions. Key research thrusts include identifying targets and approaches to defend, repair, and regenerate respiratory function, as well as technology development and therapeutic strategies to overcome current barriers. The training will also integrate clinical research and provide trainees access to patient data and samples to inform their work.
Generated 3/4/25, 8:28 AM